All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The gvhd Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the gvhd Hub cannot guarantee the accuracy of translated content. The gvhd and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View gvhd content recommended for you
Elevated intestinal epithelial tight junction permeability leads to systemic graft-versus-host disease propagation
On 1 February 2019, Sam C. Nalle from the Department of Pathology, The University of Chicago, Chicago, Illinois, USA, and colleagues published their analysis in The Journal of Clinical Investigation, on the impact of dysregulated intestinal permeability on the subsequent graft-versus-host disease (GvHD) propagation phase. Myosin light chain kinase (MLCK210), a serine/threonine-specific protein kinase that phosphorylates a specific myosin light chain, namely the regulatory light chain of myosin II, is also known as a key regulator of tight junction permeability. The study group hypothesized that MLCK210-dependent alterations in barrier function may drive GvHD propagation.
Methods
- Duodenal biopsies from patients with GvHD collected > 2 weeks post-transplant
- Donor female 129S6 and BALB/c mice
- Immunohistochemistry and immunofluorescence were performed
- Allogeneic bone marrow transplantation (allo-BMT)
- Cytokine measurements: ELISA – Ready-SET-Go! Kits
- MLCK210 transcript quantification
- Intestinal and vascular permeability assays
- Flow cytometry
Key findings
- MLCK210 activity and expression were elevated in human GvHD
- Intestinal epithelial MLCK210 upregulation and activity were increased after allo-BMT in mice
- Genetic MLCK210 inhibition in GvHD mouse model limited paracellular permeability and MLC phosphorylation in intestinal epithelia, but did not prevent increased microvascular permeability
- MLCK210-dependent processes contribute to systemic GvHD progression but has no effect on the initiation phase
- Cumulative GvHD severity and disease propagation are driven by MLCK210-dependent regulation of intestinal epithelial permeability
- MLCK210 deletion controls propagation of major antigen mismatch GvHD
- Intestinal epithelial MLCK210 is a key regulator of GvHD pathogenesis
- MLCK210 expression in the intestinal epithelium ameliorates the cytolytic function of CD8+ effector T cells within regional lymph nodes and this could be the major mechanism behind increased intestinal epithelial tight junction permeability and GvHD propagation
In conclusion, these findings demonstrate that MLCK210-mediated intestinal epithelial barrier dysfunction is a key driver to systemic GvHD propagation. These data also show that non-hematopoietic functions can be targeted, epithelial barrier integrity for instance, which may offer an alternative target for the treatment of GvHD.
References